Ultraschall Med 2018; 39(01): 39-47
DOI: 10.1055/s-0042-120258
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Interlobar Artery Resistive Index predicts Acute-on-Chronic Liver Failure Syndrome in Cirrhotic Patients with Acute Decompensation

Interlobärer arterieller resistiver Index als Prädiktor für akut-auf-chronisches Leberversagen bei zirrhotischen Patienten mit akuter Dekompensation
Pablo A. Solís-Muñoz
1   Institute of Liver Studies, King's College Hospital, London, United Kingdom of Great Britain and Northern Ireland. Angloamerican Medical Unit. Gastroenterology and Hepatology. Madrid. Spain.
5   Gastroenterology and Hepatology Research. Biomedical Research Unit. University Hospital "12 de Octubre". Complutense University, School of Medicine, Madrid, Spain
,
Christopher Willars
2   Institute of Liver Studies. LITU. King's College Hospital, London, United Kingdom of Great Britain and Northern Ireland
,
Julia Wendon
2   Institute of Liver Studies. LITU. King's College Hospital, London, United Kingdom of Great Britain and Northern Ireland
,
George Auzinger
2   Institute of Liver Studies. LITU. King's College Hospital, London, United Kingdom of Great Britain and Northern Ireland
,
Michael A. Heneghan
3   Institute of Liver Studies, Hepatology King's College Hospital NHS Foundation Trust, London, United Kingdom of Great Britain and Northern Ireland
,
Maria De la Flor-Robledo
4   Anesthesiology, University Hospital Severo Ochoa, Leganes (Madrid), Spain
,
José A. Solís-Herruzo
5   Gastroenterology and Hepatology Research. Biomedical Research Unit. University Hospital "12 de Octubre". Complutense University, School of Medicine, Madrid, Spain
› Author Affiliations
Further Information

Publication History

06 March 2016

08 October 2016

Publication Date:
18 April 2017 (online)

Abstract

Introduction Patients with acutely decompensated (AD) cirrhosis are at risk for developing acute-on-chronic liver failure (ACLF) syndrome. This syndrome is associated with a high short-term mortality rate. The aim of our study was to identify reliable early predictors of developing ACLF in cirrhotic patients with AD.

Patients and Methods We assessed 84 cirrhotic patients admitted for AD without ACLF on admission. We performed routine blood testing and detailed ultrasound Doppler studies of systemic arteries and mayor abdominal veins and arteries. We also calculated liver-specific and intensive care unit predictive scores. The area under the ROC curve (AUROC) was calculated for all variables that were significantly different between patients who developed ACLF and those who did not. Sensitivity, specificity, positive and negative predictive values, as well as diagnostic accuracy predicting the short-term development of ACLF were determined.

Results of the 84 patients, 23 developed ACLF whereas 61 did not. In the univariate analysis, serum levels of creatinine and urea, prothrombin time ratio, MELD score, portal vein and femoral artery flow velocity as well as the renal and interlobar artery resistive indices (RI) were associated with the short-term development of ACLF. However, only interlobar artery RI had independent predictive value in the multivariate analysis. The AUROC value for RI of the interlobar arteries was 0.9971.

Conclusion On the first day of admission, ultrasound measurement of the RI of the interlobar arteries recognizes with high predictive accuracy those cirrhotic patients admitted with AD who will develop ACLF during hospital admission.

Zusammenfassung

Einleitung Bei Patienten mit akut dekompensierter (AD) Zirrhose besteht ein Risiko für Ausprägung eines akut-auf-chronischen Leberversagens (ACLF). Dieses Syndrom ist mit einer hohen Kurzzeit-Mortalitätsrate assoziiert. Ziel der Studie ist die Ermittlung von frühen Prädiktoren einer beginnenden ACLF bei zirrhotischen Patienten mit AD.

Patienten und Methoden Wir bewerteten 84 zirrhotische Patienten mit AD bei Aufnahme jedoch ohne ACLF. Wir führten Routine-Blutbilder und eine detaillierte dopplersonografische Untersuchung der systemischen Arterien und der abdominalen Hauptvenen und Arterien durch. Wir berechneten auch die prädiktiven leberspezifischen und intensivmedizinischen Scores. Die „area under the ROC curve“ (AUROC) wurde für alle Variablen errechnet, die signifikante Unterschiede zwischen den Patienten, die eine ACLF entwickelten und solchen die keine bekamen, aufwiesen. Sensitivität, Spezifität, positive und negative Vorhersagewerte, sowie die diagnostische Treffsicherheit für die Vorhersage einer sich innerhalb kurzer Zeit entwickelnden ACLF wurden bestimmt.

Ergebnisse Bei 23 von 84 Patienten entwickelte sich eine ACLF, während 61 keine bekamen. In der univariaten Analyse waren die Serumspiegel für Kreatin und Harnstoff, die Prothrombin-Zeit, der MELD-Score und die arterielle Flussgeschwindigkeit der Pfortader und der femoralen Arterie sowie die renalen und interlobären arteriellen resistiven Indizes (RI) mit einer sich demnächst entwickelnden ACLF assoziiert. Allerdings zeigte in der multivariaten Analyse nur der interlobäre arterielle RI einen unabhängigen Vorhersagewert. Der AUROC-Wert des RI der interlobären Arterien betrug 0,9971.

Schlussfolgerung Am ersten Tag der Aufnahme in das Krankenhaus erkennt die sonografische Messung des RIs der interlobären Arterien mit hoher Vorhersagekraft diejenigen zirrhotischen Patienten mit AD, die im Laufe ihres Aufenthalts eine ACLF entwickeln werden.

 
  • References

  • 1 Moreau R. Jalan R. Gines P. et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013; 144: 1426-1437
  • 2 Jalan R. Gines P. Olson JC. et al. Acute-on-chronic liver failure. J Hepatol 2012; 57: 1336-1348
  • 3 Sarin SK. Kumar A. Almeida JA. et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Hepatol Int 2009; 3: 269-282
  • 4 Cholongitas E. Senzolo M. Patch D. et al. Review article: scoring systems for assessing prognosis in critically ill adult cirrhotics. Aliment Pharmacol Ther 2006; 24: 453-464
  • 5 Knaus WA. Draper EA. Wagner DP. et al. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-829
  • 6 Vincent JL. Moreno R. Takala J. et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/ failure. Intensive Care Med 1996; 22: 707-710
  • 7 Child C. Turcotte J. The liver and portal hypertension. In: Child CI. (ed.) Surgery and Portal Hypertension. 2nd ed. Philadelphia, USA: WB Saunders; 1964: 50-58
  • 8 Pugh RN. Murray-Lyon IM. Dawson JL. et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649
  • 9 Malinchoc M. Kamath PS. Gordon FD. et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-871
  • 10 Kim WR. Biggins SW. Kremers WK. et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008; 359: 1018-1026
  • 11 Cholongitas E. Senzolo M. Patch D. et al. Risk factors, sequential organ failure assessment and model for endstage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther 2006; 23: 883-893
  • 12 Wehler M. Kokoska J. Reulbach U. et al. Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems. Hepatology 2001; 34: 255-226
  • 13 Jalan R. Saliba F. Pavesi M. et al. CANONIC study investigators of the EASL-CLIF Consortium. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol 2014; 61: 1038-1047
  • 14 Theocharidou E. Pieri G. Mohammad AO. et al. The Royal Free Hospital score: a calibrated prognostic model for patients with cirrhosis admitted to intensive care unit. Comparison with current models and CLIF-SOFA score. Am J Gastroenterol 2014; 109: 554-562
  • 15 Gustot T. Fernandez J. Garcia E. et al. Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis. Hepatology  2015; 62: 243-252
  • 16 Youden WJ. Index for rating diagnostic tests. Cancer 1950; 3: 32-35
  • 17 National Institutes of Health Consensus Development Conference Statement: Liver Transplantation 1983, June 20–23. Hepatology 1984 4. (Suppl. 1) 107S-110S
  • 18 Platt JF. Duplex Doppler evaluation of native kidney dysfunction: obstructive and non obstructive disease. Am J Roentgenol 1992; 158: 1035-1042
  • 19 Maroto A. Ginès A. Saló J. et al. Diagnosis of functional renal failure of cirrhosis with Doppler sonography: prognostic value of resistive index. Hepatology 1994; 20: 839-844
  • 20 Sacerdoti D. Bolognesi M. Merkel C. et al. Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultrasonography. Hepatology 1993; 17: 219-224
  • 21 Fouad YM. Mokarrab H. Elgebaly AF. et al. Renal duplex doppler ultrasound in patients with HCV related liver cirrhosis. Trop Gastroenterol 2009; 30: 213-218
  • 22 Kastelan S. Ljubicic N. Kastelan Z. et al. The role of duplex-doppler ultrasonography in the diagnosis of renal dysfunction and hepatorenal syndrome in patients with liver cirrhosis. Hepatogastroenterology 2004; 51: 1408-1412
  • 23 Nix DE. Erstad BL. Nakazato PZ. et al. Estimation of creatinine clearance in end-stage liver disease. Ann Pharmacother 2006; 40: 900-908
  • 24 Demirtas S. Bozbas A. Akbay A. et al. Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome. Clin Chim Acta 2001; 311: 81-89
  • 25 Garcia-Tsao G. Parikh CR. Viola A. Acute kidney injury in cirrhosis. Hepatology 2008; 48: 2064-2077
  • 26 Ginès P. Guevara M. Arroyo V. et al. Hepatorenal syndrome. Lancet 2003; 362: 1819-1827
  • 27 Kew MC. Brunt PW. Varma RR. et al. Renal and intrarenal blood-flow in cirrhosis of the liver. Lancet 1971; 2: 504-510
  • 28 Salerno F. Gerbes A. Ginès P. et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 2007; 56: 1310-1318
  • 29 Aggarwal A. Ong JP. Younossi ZM. et al. Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU. Chest 2001; 119: 1489-1497
  • 30 Afessa B. Kubilis PS. Upper gastrointestinal bleeding in patients with hepatic cirrhosis: clinical course and mortality prediction. Am J Gastroenterol 2000; 95: 484-489
  • 31 Agarwal B. Davenport A. Difficulties in diagnosing acute kidney injury post liver transplantation using serum creatinine based diagnostic criteria. World J Hepatol 2014; 6: 696-703
  • 32 Singh N. Gayowski T. Wagener MM. et al. Outcome of patients with cirrhosis requiring intensive care unit support: prospective assessment of predictors of mortality. J Gastroenterol 1998; 33: 73-79
  • 33 Tsai MH. Chen YC. Ho YP. et al. Organ system failure scoring system can predict hospital mortality in critically ill cirrhotic patients. J Clin Gastroenterol 2003; 37: 251-257
  • 34 Zimmerman JE. Wagner DP. Seneff MG. et al. Intensive care unit admissions with cirrhosis: risk- stratifying patient groups and predicting individual survival. Hepatology 1996; 23: 1393-1401
  • 35 Lee M. Lee JH. Oh S. et al. CLIF-SOFA scoring system accurately predicts short-term mortality in acutely decompensated patients with alcoholic cirrhosis: a retrospective analysis. Liver Int 2015; 35: 46-57
  • 36 Kawai T. Kamide K. Onishi M. et al. Relationship between renal hemodynamic status and aging in patients without diabetes evaluated by renal Doppler ultrasonography. Clin Exper Nephrol  2012; 16: 786-791
  • 37 Spadaro L. Privitera G. Fede G. et al. Diabetes increases renovascular impedance in patients with liver cirrhosis. Intern Emerg Med  2015; 10: 703-709
  • 38 Bajaj JS. O'Leary JG. Reddy KR. et al. Survival in infection related acute-on-chronic liver failure is defined by extrahepatic organ failures. Hepatology 2014; 60: 250-256
  • 39 Dhiman RK. Agrawal S. Gupta T. et al. Chronic Liver Failure-Sequential Organ Failure Assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-on-chronic liver failure and predicting outcome. World J Gastroenterol 2014; 20: 14934-14941